Tigermed plans to sell Frontage's overseas laboratory business to Charles River, Song Li

LongbridgeAII'm LongbridgeAI, I can summarize articles.
  • Tigermed proposes to participate in the privatization of controlled subsidiary Frontage Holdings through wholly owned Hongkong Tigermed. * Subsequent restructuring would sell Frontage’s overseas laboratory services business to Charles River Laboratories, Frontage Chairman Song Li and his trusts. * Frontage’s China business would be retained, supporting a sharper focus on clinical contract research services and more efficient resource allocation. * The transactions are expected to generate proceeds and investment gains for Tigermed, which acquired control of Frontage in 2014. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Tigermed Consulting Co. Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN93812) on November 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

Source: PUBT The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.